In this study, the trochlear groove was abnormally shallow and flat in the tumor group, the FTA was significantly (P < 0.001) greater in the tumor than in the control group (159.19º ± 9.42º vs. 135.00º ± 5.50º), whereas the LPI (14.69º ± 8.91º vs. 20.73º ± 3.51º, P = 0.01) and TD (3.10 ± 1.79 vs. 6.67 ± 1.26 mm, P < 0.001) were significantly smaller in the tumor group than in the control group. No significant (P > 0.05) difference existed in the other parameters regarding patellar shift and dislocation (P > 0.05), which may indicate no dislocation or shift of patella in patellar tumors and tumor-like lesions. Significantly, different FTA, LPI and TD in the tumor group may indicate femoral trochlear dysplasia that is a geometric abnormality of the depth and morphology of the trochlear groove primarily at its cranial part. Femoral trochlear dysplasia may cause patellar instability which in turn leads to injury to the patellofemoral joint and anterior knee pain, consequently playing a role in the development of patellar tumors and tumor-like lesions (
8,
10).
Patellar tumors were rare, and among 6322 unreported cases with tumors and tumor-like lesions in the skeletal system that had been confirmed by histopathology in our hospital in a span of 45 years, only 29 cases were patellar tumors accounting for only 0.45% of the cases. Benign patellar tumors were more frequent than malignant ones in this study (69.2% vs. 30.8%), similar to what has been reported in the literature (73% of benign vs. 27% of malignant tumors) (
1). Studies conducted by Moser et al. (
13) and Singh et al. (
14) also confirmed that patellar tumors are mostly benign. The most common benign patellar tumor has been reported to be giant cell bone tumor (
14) or chondroblastoma (
13), but in our study, the most common type was chondroblastoma followed by giant cell tumor. Among 279 cases of benign patellar tumors reported by Mercuri et al. (
1), the prevalence of benign tumors was in the following order: giant cell bone tumor in 126 cases, chondroblastomas in 61, chondromas in 19, primary aneurysmal bone cysts in 15, bone cysts in 14, osteoid osteomas in 10, osteoblastomas and osteochondromas in nine, hemangiomas in eight, ganglions in four, lipomas in two, nonossifying fibroma in one, and osteoma in one. For malignant tumors, the most common type was metastases followed by osteosarcoma, similar to what has been reported in the literature (
1,
13-
16). Mercuri et al. reported 105 cases of patellar malignant tumors with metastases in 45 cases, osteosarcoma in 25, lymphoma in 14, hemangioendothelioma in 11, malignant fibrous histiocytoma in six, plasmacytoma in two, and angiosarcoma in two (
1).
The onset age range of benign and malignant tumors of the patella overlapped in this study, with relatively younger patients of chondroblastoma between 10 and 20 years of age, which was nearly ten years younger than that for giant cell bone tumor. The age range for giant cell tumor of the bone was 21 - 41 years with a mean of 30 years. Malignant patellar tumors are very rare with the frequent bone metastatic lesion occurring in older patients with a mean age of 42 years in our study. The mean age of osteosarcoma was different in the patella compared to the long bone in teenagers, with the mean age in patella greater at a mean age of 36 years. Except for giant cell bone tumor, other tumors had a greater prevalence in male than in female patients, especially for chondroblastoma.
The main symptom at presentation is unilateral anterior knee pain, similar in nature to pain caused by degenerative osteoarthritis or chondromalacia (
2). Benign tumors usually have a long history of over one year. The disease history is very important in the early diagnosis of benign lesions especially the nature and duration of pain, with rest pain at night in particular being one crucial clue. Malignant patellar tumors have no apparent swelling, pain or bone destruction in early periods but progress very rapidly mostly in older patients whose diagnosis is frequently delayed because the symptoms are often mistaken as degenerative osteoarthritis. Significant delay in diagnosis usually occurs due to the non-specific complaint and rarity of patellar tumors, with the mean duration of 17 (4 - 36) months between symptom onset and definitive diagnosis (
2). Subtle radiological alterations can readily be neglected at initial assessment.
Chondroblastoma accounts for 1% - 3% of benign primary tumors of the bone with 4% - 6% occurring in the patella (
13,
14,
17). Most chondroblastomas arise in the epiphysis of an immature long bone in the second decade of life. In our series with nine cases, the man age was 21 years at presentation (range, 10 - 43 years). The radiographic appearance of chondroblastoma was relatively small with slight expansion, a sclerotic rim of reactive bone and irregular calcification within the lesion in 30% - 50% of the cases. These imaging features were significantly important for correct diagnosis.
About 5% - 9% of all primary bone tumors are giant cell bone tumors, and of all these tumors in the skeletal system, less than 1% happens in the patella typically in the third decade of life (
18,
19). The imaging characteristics in the patella are not different from other bone locations but are usually greater in size compared with chondroblastomas. Giant cell bone tumors are cystic lytic bone destruction with expansive thinned cortex, no calcification inside the lesion, clear rims but no apparent sclerosis of the rim. Septations may be seen inside the lesion. Giant cell bone tumors are locally aggressive with 1% - 2% pulmonary metastases being reported (
14). In our case series, none of these tumors had metastases.
Patellar metastatic tumors are less frequent than primary ones, and the rarity of these metastases have been attributed to the relatively distal localization and fairly poor blood supply of this sesamoid bone. In metastasis, the most common primary tumor is lung carcinoma probably through direct arterial dissemination similar to the phalanges (
2,
20). The patellar metastatic lesion is mostly a lytic destruction with ill-defined margins, lacking periosteal reaction and sclerotic rims and accompanied with a soft tissue mass. Nonetheless, the imaging appearance may also be mixed with osteogenic and osteolytic appearance. Osteosarcomas in the patella have no specific imaging features and can present as osteosclerotic and osteolytic destruction with different extents, erosion of the cortex, and a soft tissue mass.
Patellar tumors or tumor-like lesions must be differentiated in radiological imaging from other bone tumors. Osteoblastomas are cystic expansive destruction with sclerotic rims and calcification and may be difficult to be differentiated from giant cell tumors in cases with no calcifications. Osteochondromas are bony masses mostly located at the distal end of the patella with a wide base to connect with the patella. Other diseases in the patella are extremely rare. Bone cysts may be like an expansive cyst with possible pathological fractures and fluid-fluid level in the lesion. Aneurysmal bone cysts are beehive-like lytic destruction with small fine septations inside the lesion but no sclerotic rims, and these signs are quite different from those of fibrous dysplasia which is of a beehive-like lytic lesion with coarse septations and sclerotic rims. The patellar hemangioma lesion was similar to chondroblastoma in imaging; however, patellar hemangioma occurs in relatively older patients with interior calcification, high CT values inside the lesion and bone crests at the lesion edge. Other diseases in the patella do not have particular imaging characteristics, and when plain radiographs are normal, computed tomographic scans are very useful since they can precisely demonstrate the nidus and location of the lesion.
In conclusion, the patellar tumors are mainly benign and rarely malignant. Comprehensive understanding of the distribution, incidence and imaging features of patellar tumors and patellofemoral morphological parameters could improve the diagnostic accuracy.